宜明昂科-B回购5.56万股股份，耗资约20.14万港元

公告速递07-08

宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月8日公告，开展股份购回，回购数量为55,600股，占当时已发行股本的约0.0133%。回购价格区间介乎每股3.58港元至3.67港元，合计耗资约20.14万港元。

本次购回完成后，公司已发行股本为418,754,305股，库藏股数量增至1,723,000股。公司于2026年5月28日获得购回授权，总授权购回数量为43,150,769股，截至目前累计已回购1,723,000股，占授权通过当日已发行股本的约0.399%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由执行董事、联席公司秘书关梅签署。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1146874591?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-08 20:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146874591","market":"hk","top_or_hot":-1,"title":"宜明昂科-B回购5.56万股股份，耗资约20.14万港元","media":"公告速递","content":"<p>宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月8日公告，开展股份购回，回购数量为55,600股，占当时已发行股本的约0.0133%。回购价格区间介乎每股3.58港元至3.67港元，合计耗资约20.14万港元。</p>\n<p>本次购回完成后，公司已发行股本为418,754,305股，库藏股数量增至1,723,000股。公司于2026年5月28日获得购回授权，总授权购回数量为43,150,769股，截至目前累计已回购1,723,000股，占授权通过当日已发行股本的约0.399%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由执行董事、联席公司秘书关梅签署。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>宜明昂科-B回购5.56万股股份，耗资约20.14万港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n宜明昂科-B回购5.56万股股份，耗资约20.14万港元\n</h2>\n\n<h4 class=\"meta\">\n\n2026-07-08 20:36 北京时间&nbsp;&nbsp;&nbsp;<strong>公告速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月8日公告，开展股份购回，回购数量为55,600股，占当时已发行股本的约0.0133%。回购价格区间介乎每股3.58港元至3.67港元，合计耗资约20.14万港元。\n本次购回完成后，公司已发行股本为418,754,305股，库藏股数量增至1,723,000股。公司于2026年5月28日获得购回授权...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01541","symbol_name":"宜明昂科-B","start_time":0,"source_url":"","article_id":"1146874591","we_media_id":"1097772564","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146874591","pubTimestamp":1783514179,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"公告速递","introduction":"港美股公告全覆盖","home_visible":1,"id":"1097772564","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"宜明昂科生物医药技术（上海）股份有限公司于2026年7月8日公告，开展股份购回，回购数量为55,600股，占当时已发行股本的约0.0133%。回购价格区间介乎每股3.58港元至3.67港元，合计耗资约20.14万港元。本次购回完成后，公司已发行股本为418,754,305股，库藏股数量增至1,723,000股。公司于2026年5月28日获得购回授权，总授权购回数量为43,150,769股，截至目前累计已回购1,723,000股，占授权通过当日已发行股本的约0.399%。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01541":"宜明昂科-B"},"translate_title":"Yiming Onco-B repurchased 55,600 shares at a cost of approximately HK$201,400","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01541":1},"content_text":"宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月8日公告，开展股份购回，回购数量为55,600股，占当时已发行股本的约0.0133%。回购价格区间介乎每股3.58港元至3.67港元，合计耗资约20.14万港元。\n本次购回完成后，公司已发行股本为418,754,305股，库藏股数量增至1,723,000股。公司于2026年5月28日获得购回授权，总授权购回数量为43,150,769股，截至目前累计已回购1,723,000股，占授权通过当日已发行股本的约0.399%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由执行董事、联席公司秘书关梅签署。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146874591","isCrawlerRequest":true}